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Abstract
Background: Many intervention-based studies aiming to improve mental health do not include a
multi-attribute utility instrument (MAUI) that produces quality-adjusted life-years (QALYs) and it limits
the applicability of the health economic analyses. This study aims to develop ‘crosswalk’ transformation
algorithm between a measure for psychological distress General Health Questionnaire (GHQ-12) and MAUI
EuroQoL (EQ-5D-3L).
Methods: The study is based on a survey questionnaire sent to a random sample in four counties in
Sweden in 2012. The survey included GHQ-12 and EQ-5D instruments, as well as a question about self-rated
health. The EQ-5D index was calculated using the UK and the Swedish tariff values. Two OLS models were
used to estimate the EQ-5D health state values using the GHQ-12 as exposure, based on the respondents
(n = 17, 101) of two counties. The algorithms were applied to the data from two other counties, (n = 15, 447)
to check the predictive capacity of the models.
Results: The final models included gender, age, self-rated health and GHQ-12 scores as a quantitative variable.
The regression equations explained 40 % (UK tariff) and 46 % (Swedish tariff) of the variances. The model
showed a satisfying predictive capacity between the observed and the predicted EQ-5D index score, with
Pearson correlation = 0.65 and 0.69 for the UK and Swedish models, respectively.
Conclusion: The algorithms developed in this study can be used to determine cost-effectiveness of services or
interventions that use GHQ-12 as a primary outcome where the utility measures are not collected.
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Background
Well-being is an important determinant of health and
social outcomes. Health influences wellbeing and well-
being itself influences health, thus health is one of the
top things people say matters for wellbeing [1]. Accord-
ing to [2], both physical health and mental health can in-
fluence wellbeing. Mental health is defined as a state of
well-being while the positive dimension of mental health
is stressed in WHO’s definition of health: “Health is a
state of complete physical, mental and social well-being
and not merely the absence of disease or infirmity” [3].
Nevertheless, mental health problems account for a sub-
stantial burden of disease globally, with the World
Health Organization predicting that by 2030, mental
health problems will be the highest-ranking disease in
terms of burden in affluent countries [4]. Consequently,
numerous researchers have designed and evaluated di-
verse interventions that aim to improve mental health
among different population groups. We can name risk
management interventions [5, 6], community programs
to improve health behaviors and mental well-being [7],
parenting programs [8, 9], healthcare strategies [10, 11]
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and treatments [12], and many others. These interventions
are carried out in different societal sectors (government,
municipality, healthcare, etc.); however, the same instru-
ment, General Health Questionnaire (GHQ-12), is used
when evaluating their efficacy/effectiveness. The General
Health Questionnaire (GHQ) is a measure of the current
mental health, and since its development by Goldberg in
the 1970s [13], it has been extensively used in different
settings and different cultures. GHQ-12 is often used ac-
cording to a common approach to assess the outcomes of
health interventions, that is, to obtain personally reported
description of mental health status across various dimen-
sions and then to apply a numerical scoring system.
At the same time, the implementation of effective in-
terventions is often questioned because of the scarcity of
available resources to meet the growing demands for
healthcare and social services. That is why the interest
in economic evaluation as a tool to inform resource allo-
cation has increased over time. The aim of economic
evaluation of different interventions targeted mental
health problems is to allow the comparison of the cost-
effectiveness of services in different societal sectors, such
as healthcare, municipality care, public health interven-
tions, etc. In this way, decision makers can be informed
about where the greatest net benefits could be obtained.
The technique of cost-utility analysis allows for such
comparisons, both within and across societal sectors. In
this framework, costs are measured in monetary terms
and outcomes are measured in a generic common unit
such as quality-adjusted life-years (QALYs). There are a
number of multi-attribute utility instruments (MAUIs)
that measure health-related quality of life, but they
uniquely have a ‘utility’ algorithm that converts people’s
responses to a single utility score measured on a 0–1
scale, where 0 denotes death and 1 denotes the best
health outcome measured by the instrument. The utility
scores produced by these instruments, in principle,
measure the strength of the people’s preference for the
health state. To obtain QALYs, the utility of a health
state is multiplied by the length of time spent in the par-
ticular health state. The most commonly used MAUI for
evaluating both the mental and physical disorders is the
EuroQoL–five dimension (EQ-5D). Its advantages are
both brevity and simplicity, comparison with other com-
monly used MAUI like SF-6D, HUI, AoQL-8D, and
others [14]. Nonetheless, GHQ-12, which is often used
in evaluating mental health promotion interventions,
cannot be used in cost-utility analyses to estimate cost
per quality adjusted life year (QALY), as it is not
preference-based. As was mentioned by Brazier et al.
(2010), “this lack of use of generic preference-based
measures is a barrier to population economic models
with the best evidence on effectiveness” [15]. The
authors suggest using the mapping technique as a
possible solution to the predicted health state utility
values when only a no preference-based measure, like
GHQ-12, has been included in the study. This approach
requires that the two measures be administered on the
same population, and it involves estimating the relation-
ship between a non-preference-based measure and a
generic preference-based measure using so called ‘cross-
walking’ [16]. Typically, mapping uses two datasets: an es-
timation dataset that contains respondents’ self-reported
scores for their own health using two or more preference
and non-preference-based measures, and a study dataset
containing only the non-preference-based measure. Re-
gression techniques are usually used on the estimation
dataset to determine a statistical relationship between the
measures, and the results are then applied to the study
dataset to obtain predicted health state utility values.
To the best of our knowledge, there are three studies es-
timating mapping functions from specific mental health
measures into generic preference-based measures of
health. The study by Brazier et al. [17] presented mapping
functions between GHQ-12 and SF-6D using the total
GHQ-12 score and the items to predict the SF-6D scores.
Analyses were based on groups of people with mental
health problems, from moderate to severe. Another study
by Mihalopoulos et al. [18] compared the sensitivity of five
commonly used MAUIs (including EQ-5D) with disease-
specific depression outcome measures and developed
‘crosswalk’ transformation algorithms between the mea-
sures. Both studies aimed to estimate the functions to
predict the MAUIs scores from mental health-specific
measures commonly used in the mental health services.
The third study by Serrano-Aguilar et al. [19] is only one
study that estimates the relationship among mental health
status measured by GHQ12, Health Related Quality of
Life (EQ-5D), and Health-State Utilities in a general popu-
lation [19]; however, the findings have limited applicability
because the authors did not follow the recommendations
[15]; specifically, they did not include other health mea-
sures in the model, and the model was not applied to an-
other population to test the predictability and accuracy.
The aim of this study is to assess the relationship
between the commonly used measures for psychological
distress General Health Questionnaire (GHQ12) and
MAUI EuroQoL (EQ-5D-3L), and develop ‘crosswalk’
transformation algorithm between the measures. This al-
gorithm can be used to determine the cost-effectiveness of
services or interventions that use GHQ-12 as a primary




The 3L version of the EQ-5D questionnaire is the
standard version that has been used in hundreds of
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clinical trials and methodological studies published in the
peer-reviewed literature [20]. It is a brief self-reported
measure of generic health that consists of five dimensions
(mobility, self-care, usual activities, pain/discomfort, and
anxiety/depression), each with three levels of functioning
(e.g., no problems, some problems, and extreme problems).
This health state classifier can describe 243 unique health
states that are often reported as vectors ranging from
11,111 (full health) to 33,333 (worst health). Numer-
ous societal value sets have been derived from the
population-based valuation studies around the world
which, when applied to the health state vector, result
in a preference-based score that typically ranges from
states worse than dead (>0) to 1 (full health), anchor-
ing dead at 0.
EQ-5D-3L value set
Research carried out by EuroQol Group members has
concentrated on statistical modeling to generate values
for all the 243 theoretically possible health states defined
by EQ-5D-3L. A set of weights that represent the gen-
eral population’s preferences might be the ideal system
of choice, but such a system is not always available. A
country-specific value set for EQ-5D health states was
first generated in the UK [21] based on hypothetical
values derived from a sample of the general population.
The National Institute for Health and Clinical Excellence
(NICE) in England and Wales recommends using this
UK EQ-5D ‘social tariff ’ for QALY weightings [22]. In
the absence of a set of national population-based utility
weights, the majority of cost-effectiveness research
adopted the UK value set.
In Sweden, the Dental and Pharmaceutical Benefits
Agency (TLV) states that QALY weightings can be based
either on direct or indirect measurements (‘where a health
classification system such as EQ-5D is linked to QALY
weightings’) and that ‘QALY weightings based on ap-
praisals of persons in the health condition in question are
preferred before weightings calculated from an average of
a population estimating a condition depicted for it (e.g.,
the ‘social tariff ’ from EQ- 5D)’ [23]. It means that TLV
prefers experience-based rather than hypothetical values.
A recently published study by Burström et al. [24] pre-
sented the estimations of experience-based Swedish value
set for EQ-5D-3L health states.
In our study, we use two different value sets for
EQ-5D health states:
1) The UK value sets, based on the hypothetical
values derived from a sample of the general
population [21] and
2) The Swedish experience-based value sets for EQ-5D
health states derived from a general population
health survey data [24].
GHQ-12
GHQ-12 is one of the most widely used screening tests
to detect psychiatric morbidity in community settings
and non-psychotic psychiatric disorders in clinical set-
tings, and it is designed as a structured, brief, and self-
administered questionnaire [13]. Every one of its 12
items regarding recent symptoms, feelings, or behaviors
is answered on a four-category Likert scale. Categories 1
and 2 are given value 0, and categories 3 and 4 are given
value 1. Values from 12 items are added together to get
an overall score. A probable psychiatric case is consid-
ered when the score is equal to or greater than 3.
The SRH question
Self-rated health (SRH) was measured by the question:
“How do you rate your general health?” with the options
‘very good,’ ‘good,’ ‘neither good nor poor,’ ‘poor,’ and
‘very poor.’
Material/study population
Data were obtained from the cross-sectional postal survey
questionnaires, conducted during March–May 2012. The
surveys were addressed to random population samples of
men and women, aged 16–84 years, from 39 municipalities
in 4 counties in the central part of Sweden. Together, the
four counties have about one million inhabitants in this
age range. The sampling was random and stratified by gen-
der, age group, and municipality; the response rate was
51 %. The data collection was completed after two postal
reminders. Corresponding surveys have been undertaken
in 2000, 2004, and 2008 [25, 26]. The respondents gave
their informed consent so that questionnaire data could be
linked to the Swedish official registries through the individ-
uals’ personal identification numbers. All handling of per-
sonal identification numbers was carried out by Statistics
Sweden, the statistical administrative authority in Sweden.
The EQ-5D-3L self-report descriptive system was
transformed into utility values using the English (EQ-
5D-UK) and Swedish (EQ-5D-SW) value sets. The
General Health Questionnaire (GHQ-12) and a self-rated
health (SRH) questionnaire were included in this study,
along with information about age and sex. The total study
sample included 32,548 respondents, while data from re-
spondents of two counties (Estimation sample, n = 17,101)
were used for the statistical analyses and deriving of cross-
work algorithms. The algorithms were applied to the
survey data of the respondents from another two counties,
(Validation sample, n = 15,447) to check the predictive
capacity of the models. The survey sampling results are
presented on Fig. 1.
Analyses
All analyses were performed with IBM SPSS Statistics,
version 23.
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Total sample
For description of the scales: mean, standard deviation,
median, range, ceiling effect, floor effect, and skewness
were used. The distribution of the categorical variables
was described with numbers and percentages. For the
description of the relation between the GHQ-12 and
health utility, the mean and standard deviation was
calculated for each level of GHQ-12. Description of
variables in the two samples were performed with
number and percentages for categorical variables and
with mean and standard deviation for quantitative
variables. Test of difference between the two subsam-
ples were performed with Pearson Chi-square test for
categorical variables and with independent samples t-test
for quantitative variables. Further, Cohen’s effect size
measure was calculated for quantifying the difference
between the subsamples regarding the scale means.
Estimation sample
The aim was to build two models, one that related the
GHQ-12 to the EQ-5D-UK and one that related the
GHQ-12 to the EQ-5D-SW. Health utility measures
often show a truncation effect where a proportion of the
individuals achieve the upper bond. However, when the
intention of the model is economic evaluation, OLS used
with robust standard errors is recommended as a simple
and valid approach [27]. Hence, the Huber sandwich
estimator was used to estimate the standard errors,
which gives robust estimates even if the underlying
model is incorrect. OLS-models were used to develop
Fig. 1 Population survey samplings results used in the study
Fig. 2 Observed and Predicted values of EQ-5D and EQ-5D-SW with 95 % error bars against GHQ-12 (Validation sample)
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the transformations between the health utility (EQ-5D-UK
and EQ-5D-SW) and the explanatory variables GHQ12 (as
a quantitative variable), self-rated health, age, and sex. The
interaction between the explanatory variables regarding
the effect on health utility was investigated by including
interaction terms in the models. Evaluation of goodness-
of-fit for different models was performed with R2 and
RMSE (root mean squared error). The final models were
presented with parameter estimates, and robust standard
errors calculated with the Huber sandwich estimator.
Validation sample
Capacity checking of the models was performed by cal-
culating Pearson correlation between the observed and
predicted values of health utility. Further evaluations of
the models were done by computing the mean and 95 %
confidence interval of the observed and the predicted
values of the health utility measures and for the absolute
errors. Forecast errors were computed by dividing the
absolute error by the mean of the observed health utility
[28]. The forecast errors were presented by the mean
and 95 % confidence intervals. Finally, the observed and
predicted values for the EQ-5D-UK and EQ-5D-SW were
plotted against the GHQ-12, divided into categories.
Estimation sample and validation sample
A sensitivity analysis of the results was performed by
analyzing the pattern of missing values in the data and
performing an iterative Markov chain Monte Carlo
(MCMC) for imputing missing values. Then the model
specification and capacity checking was performed again
for data with imputed values and those results was com-
pared to the original results.
Results
Total sample
Descriptive information regarding the distributions of
the EQ-5D-UK, EQ-5D-SW, and GHQ-12 are presented
in Table 1.
The health utility transformed with Swedish weights
(EQ-5D-SW) gives higher values with smaller variability
compared to health utility transformed with English
weights (EQ-5D-UK). Both the EQ-5D measures showed
an apparent truncation effect, with a ceiling effect of
33.4 % (highest value 1 for EQ-5D-UK and 0.97 for EQ-
5D-SW). GHQ-12 had a ceiling effect of 71.2 %, which is
very high. The relation between the GHQ-12 and the
outcomes EQ-5D-UK and EQ-5D-SW for the total sam-
ple is shown in Table 2.
The EQ-5D measures have higher values (indicated
better health) for low values on the GHQ-12 and de-
clines in a stepwise manner when the GHQ-12 values
become higher. Table 3 provides the background charac-
teristics of the two subsamples (Subsample1: Model
building, Subsample 2: Capacity checking). The distri-
butions for sex and self-rated health and the mean
values for age were almost identical in the two sub-
samples. The mean values for EQ-5D-UK and EQ-
5D-SW are similar with p-values for differences 0.985
and 0.184 respectively. The mean value for GHQ-12
is somewhat higher in Subsample 1 with a p-value of
Table 1 Description of EQ-5D-UK, EQ-5D-SW and GHQ-12
(Total sample, n = 32,548)
EQ-5D-UK: Possible values: −0.59 (poorest health) to 1 (best health)
Missing: 8.0 % (n = 2602)
Mean (SD) 0.80 (0.22)
Median (range) 0.80 (−0.59 to 1)
% Floor (−0.59) 0.03 % (n = 10)
% Ceiling (1) 33.4 % (n = 10,003)
EQ-5D-SW: Possible values: 0.34 (poorest health) to 0.97 (best health)
Missing: 8.0 % (n = 2602)
Mean (SD) 0.90 (0.09)
Median (range) 0.93 (0.34–0.97)
% Floor 0.03 % (n = 11)
% Ceiling 33.4 % (n = 10,002)
GHQ-12: Possible values: 12 (poorest health) to 0 (best health)
Missing: 3.1 % (n = 1008)
Mean (SD) 1.10 (2.42)
Median (range) 0 (0 to 12)
% Floor (12) 0.9 % (n = 290)
% Ceiling (0) 71.2 % (n = 22,448)
Table 2 Relation between GHQ12 and the outcomes EQ-5D-UK
and EQ-5D-SW (Total sample, n = 32548a)
GHQ-12 EQ-5D-UK EQ-5D-SW
n (%) Mean (SD) Mean (SD)
GHQ-12
0 20,836 (71.4) 0.85 (0.17) 0.93 (0.06)
1 2626 (9.0) 0.76 (0.22) 0.89 (0.09)
2 1458 (5.0) 0.71 (0.25) 0.87 (0.10)
3 910 (3.1) 0.69 (0.25) 0.85 (0.10)
4 724 (2.5) 0.67 (0.26) 0.84 (0.11)
5 553 (1.9) 0.63 (0.28) 0.83 (0.12)
6 463 (1.6) 0.63 (0.29) 0.82 (0.12)
7 353 (1.2) 0.58 (0.31) 0.80 (0.14)
8 286 (1.0) 0.54 (0.32) 0.78 (0.14)
9 239 (0.8) 0.53 (0.33) 0.77 (0.14)
10 223 (0.8) 0.54 (0.32) 0.77 (0.14)
11 246 (0.8) 0.44 (0.31) 0.73 (0.14)
12 270 (0.9) 0.36 (0.35) 0.69 (0.16)
aGHQ-12 3.1 % missing, EQ-5D-UK 8.0 % missing, EQ-5D-SW 8.0 % missing
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0.001. However, Cohen’s effect size measure is 0.04
which is considered trivial.
Model building (estimation sample)
To develop crosswalk transformation algorithms from
the GHQ-12 to the health utility measures, the two EQ-
5D measures were regressed with OLS upon GHQ-12,
self-reported health, age, and sex in stepwise procedure.
Evaluations of different models are presented in Table 4
with goodness of fit measures. First, the binary models
for the GHQ-12 and self-reported health were per-
formed. Then, the algorithms with all four explanatory
variables were performed, also with interaction terms.
The analyses showed that no important interaction
effects between the explanatory variables in relation
to the health utility measures were present. Inclusion
of self-reported health together with GHQ-12 was es-
sential for acceptable values on R2 and the following
algorithms were chosen for the crosswalk transforma-
tions (self-rated health = SRH; overall score of GHQ-
12 = GHQ):
Model EQ-5D-UK
0.987 - 0.001*Age + 0.025*(Gender =Man) - 0.074*(SRH =
Good) - 0.200*(SRH=Neither nor) -0.444*(SRH = Bad) -
0.660*(SRH=Very bad) - 0.019*GHQ.
Model EQ-5D-SW
0.972 - 0.0004*Age + 0.010*(Gender =Man) - 0.020*(SRH=
Good) - 0.076*(SRH=Neither nor) -0.182*(SRH=Bad) -
0.261*(SRH=Very bad) - 0.010*GHQ.
Full descriptions of the models are presented in Table 5.
Capacity checking (validation sample)
Validation of the models are presented in Table 6.
Pearson correlation between the observed and pre-
dicted values for the EQ-5D-UK and EQ-5D-SW were
0.678 and 0.715, respectively. The mean absolute error
and the mean relative forecast error were smaller for the
transformation with the Swedish weights (MAE = 0.115
for EQ-5D-UK and MAE = 0.042 for EQ-5D-SW). The
relative forecast error was larger for the smaller
observed values on the EQ-5D measure and also
smaller for the transformation with the Swedish
weights. Overall, the results from the validation of the
models (Table 6) are in line with or better than
previous research [17, 19, 28]. Figure 2 provides the
observed and predicted values for the EQ-5D-UK and
EQ-5D-SW plotted against the GHQ in six categories.
The predictions are best for the low (GHQ = 0) and
Table 3 Characteristics of the individuals (Total sample, n = 32548a)
Estimation sample Validation sample p-valueb Effect sizec
Model building n = 17,101 Capacity checking n = 15,447
Sex, n (%)
Men 7874 (46.0) 7009 (45.4) 0.226
Women 9227 (54.0) 8438 (54.6)
Self- rated health, n (%)
Very good 3048 (18.3) 2693 18.0) 0.932
Good 8191 (49.2) 7401 (49.6)
Neither nor 4354 (26.2) 3901 (26.1)
Bad 893 (5.4) 782 (5.2)
Very bad 159 (1.0) 147 (1.0)
Age, Mean (SD) 55.44 (19.44) 55.48 (18.52) 0.871
EQ-5D-UK, Mean (SD) 0.80 (0.22) 0.80 (0.22) 0.985 0.00
EQ-5D-SW, Mean (SD) 0.90 (0.09) 0.90 (0.09) 0.184 −0.01
GHQ-12, Mean (SD) 1.14 (2.46) 1.05 (2.38) 0.001 0.04
aSelf-rated health 3.0 % missing, EQ-5D-UK 8.0 % missing, EQ-5D-SW 8.0 % missing, GHQ-12 3.1 % missing
bPearson Chi-square test for categorical variables and independent samples t-test for quantitative variables
cCohen’s effect size measure









GHQ + SRH + Age + Sex 0.503 0.063
aLower values indicates better model fit
bNo important interaction effect was detected between the variables
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the upper half (GHQ = 6 to GHQ = 12) and somewhat
poorer in between.
Sensitivity analysis (estimation sample and validation sample)
An analysis of the pattern of missing values in the data
revealed that the pattern was arbitrarily and an iterative
Markov chain Monte Carlo (MCMC) method was used
for imputing missing values. Regression analyses with
EQ-5D-UK and EQ-5D-SW as outcomes were per-
formed for the data with imputed values, and capacity
checking for those models was performed by calculating
relative forecast errors (Table 7). A comparative analysis




In this study we have developed transformation algo-
rithms between the non-preference-based mental health
specific outcome measure GHQ-12 and the generic
health utility instrument EQ-5D-3L. These mapping
algorithms provide a practical solution for researchers
seeking to use existing data sets with GHQ-12 data, but
where no preference-based utility measure is used, to
facilitate an economic evaluation. Three additional vari-
ables were included in the final algorithms: age, gender,
and self-rated health to increase the performance of the
model. We do not think that this is a limitation because
such data are usually collected during the evaluation of
the mental health interventions. Different models were
constructed 1) for the UK value sets, based on the hypo-
thetical values and 2) for the Swedish preference based
value set, to increase the applicability and practical use
of the study. The prediction capacity of the Swedish
values based model was slightly better than the UK
value based one, but both models have shown the
same pattern in the error degree with the good pre-
dictive results observed for the low and the upper
half of the GHQ-12 score and poorer in between. It
means that the accuracy of the deriving quality of life
utilities is better for severe mental health problems
(in our case, when GHQ-12 scores are higher than 3).
These results, however, are in contrast to previous
observations that the degree of error tends to be lar-
ger when the health condition gets more severe, and
the utilities are usually overestimated. In agreement
with previous studies [15], we found a simple additive
model with the utility score as the dependent variable
and the GHQ-12 scores as independent variables to
be the most appropriate functional form, with the
additional patient characteristics such as age, gender,
and self-rated health having a positive impact on the
model’s performance.
Despite concerns over the use of OLS, we find this
method of estimation to be suitable in this case. A
simulation study [27] showed that when the intention
is to provide an economic evaluation and the true
utilities are bounded at 1, then the OLS model coupled
with robust standard errors is a simple and valid ap-
proach. A recent review of crosswalk studies between
MAUIs and other measures [15] found that the ex-
planatory power of studies ranged from an R2 of 0.17
to 0.71, with the majority between 0.4 and 0.5. For
Table 5 Models (Estimation sample)
EQ-5D-UK* EQ-5D-SW*
Variable Coef Std. Error Coef Std. Error
Intercept 0.987 0.0045 0.972 0.0017
Age −0.001 <0.0001 −0.0004 <0.0001
Gender
Woman ref ref
Man 0.025 0.0027 0.010 0.0011
Self-rated health
Very good ref ref
Good −0.074 0.0026 - 0.020 0.0008
Neither nor −0.200 0.0041 - 0.076 0.0016
Bad −0.444 0.0117 - 0.182 0.0045
Very bad −0.660 0.0282 −0.261 0.0114
GHQ −0.019 0.0009 −0.010 0.0004
*All estimates had a p-value < 0.001
Table 6 Capacity checking of the models (Validation sample)
EQ-5D-UK EQ-5D-SW
Pearson correlationa 0.678 (p < 0.000) 0.715 (p < 0.000)
Mean (CI) Mean (CI)
Observed values 0.800 (0.796, 0.803) 0.904 (0.902, 0.905)
Predicted values 0.808 (0.806, 0.810) 0.904 (0.903, 0.905)
Absolute error 0.115 (0.113, 0.117) 0.042 (0.041, 0.043)
Relative forecast error 14.4 % (14.1, 14.6) 4.6 % (4.5, 4.7)
Observed values ≤0.8 >0.8 ≤0.8 >0.8
Relative forecast error 15.5 % (15.1, 15.8) 12.8 % (12.5, 13.0) 13.6 % (13.2, 14.0) 3.6 % (3.5, 3.6)
aPearson correlation between observed and predicted values of health utility
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example, Mihalopoulos et al. [18] reported correlation
coefficients between depression-specific outcome mea-
sures and MAUI EQ-5D-5L between 0.45 and 0.69.
By these standards, the crosswalk between the mental
health specific outcome measure GHQ-12 and MAUI
EQ-5D-3L in this study performs well.
Strength and limitations
The study is based on the large community based
samples aimed at giving representative pictures of health
conditions in a general Swedish population with strong
statistical power. Two independent subsamples with the
same population profiles were used, one to construct the
model and another to check the models capacity. This
technique strengths the credibility and robustness of the
developed algorithms. However, the response rates of
51 % pose a risk of bias in the results, as non-
participation in health surveys has been shown to be
associated with poor health [29]. Nonetheless, there
were fewer participants in the younger age group
(16–24) compared with the general population. The
survey was also a cross-sectional design, thus, a com-
parison of the responsiveness of the instruments to
change over time could not be assessed.
The proposed model cannot be applied using only the
data set with complete responses to the GHQ-12,
which requires additional data on age, gender, and self-
rated health. It was shown that the overlap between the
GHQ12 - items and the EQ-5D-3L is very limited, since
they only share the anxiety/depression dimension [30].
That is why including of the self-rated health variable
into the model is absolutely necessary, to take into
account four other “physical” dimensions of the EQ-5D.
That means that the pertinence of the algorithms is
limited to the studies included self-rated health ques-
tionnaires additionally to the GHQ-12 survey.
Finally, although this study presents a technique for
deriving utility from the GHQ-12 instrument, while
MAUI is not included, it is important to appreciate that
this is a second best solution to the inclusion of such an
instrument in a study that aims to conduct a health
economic evaluation. Predicted utilities cannot create or
estimate the content that is not in the mental health
specific instrument, rather they can only transform the
content of the instrument to a second best estimate.
Even though the current study has provided an internal
validity of the mapping algorithms, external validation is
still required, although the big sample size and the
international context of the study help to reduce the
risks in external validity.
Conclusion
Our paper presents a set of algorithms to map from the
mental health specific instrument GHQ-12 to the health
state values, which will facilitate the cost-effectiveness
studies in this area. The models are reasonably simple,
in that any data set with complete responses to the
GHQ-12 together with the respondent’s age, gender, and
self-rated health can be used to predict the EQ-5D. The
models presented in this paper can be used to esti-
mate the mean EQ-5D-3L values in other samples.
However, future work is required to assess whether
our models would perform as well in some special
pollution groups.
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